Skip to main content
Premium Trial:

Request an Annual Quote

Bionomics to Acquire CRO Neurofit for $1.7M; CNS Tx Development Planned

NEW YORK, Dec. 17 (GenomeWeb) - Bionomics will acquire Neurofit, a French contract research organization, in a €1.25 million ($1.65 million) cash-and-stock transaction expected to close before March 1, the Adelaide, Australia-based company said today.

 

Bionomics will pay €1 million in cash and € 250,000 in shares for Strasbourg, France-based Neurofit. The company conducts preclinical testing of developmental therapeutics for CNS disorders using cellular and animal models, and lists Novartis, Serono, Boehringer-Ingelheim, and Biogen as clients.

 

The acquisition will enhace Bionomics' therapeutic development capacity for CNS disorders, Bionomics said.

 

Additionally, the acquisition includes intellectual property rights to an animal model of Parkinson's Disease, developed by Institute Pasteur, and other animal models.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.